Semnur Pharmaceuticals, Inc. (SMNRW) Operating income 2023–2025
Semnur Pharmaceuticals, Inc. (SMNRW) annual operating income history from SEC filings — each fiscal year as reported.
-$160.4MFY2025 · since FY2023: -$3.2M → -$160.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$160.4M | -3320.4% |
| FY2024 | -$4.7M | -47.8% |
| FY2023 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice